Home / Diabetes In Control (page 587)

Diabetes In Control

FDA Restricts Lap-Band Claims

FDA Restricts Lap-Band Claims “I lost 90 pounds with the Lap-Band” should also include that it has Serious Risks. FDA has warned eight surgical centers and a marketing firm in California about misleading advertising of the Lap-Band.

Read More »

Duo AutoShield™

Autoshield

Duo AutoShield™ Duo is a next generation, 5mm safety-engineered pen needle designed to protect healthcare workers from needlestick injuries and blood exposure. It is now available in the US from BD Medical. The AutoShield™ Duo is the only pen needle with front and back-end needle protection. The safety mechanisms activate …

Read More »

Linagliptin Trial Results In

Linagliptin, a DPP-4 inhibitor currently under clinical development for type 2 diabetes, produced “meaningful” reductions in blood sugar, according to results of a late-stage clinical study. The results of a 24-week, open-label arm of a phase-3 study of the investigational drug linagliptin combined with the generic drug metformin, were announced …

Read More »

SGLT2 Inhibitor Updates

In the latest results, dapagliflozin improved control when glimepiride was added. Through 48 weeks, dapagliflozin plus glimepiride reduced HbA1c levels by 0.37% to 0.70% compared with placebo plus glimepiride. There were also sustained reductions in fasting plasma glucose and post-prandial glucose and small reductions in total body weight (1.3 to …

Read More »

Eating Out Twice a Week Increases Risk of Diabetes

Two take-outs a week are enough to increase the risk of diabetes and heart disease, research shows. Young adults were more likely to have hidden health problems if they treated themselves to fast food on a twice-weekly basis, the study found. Additionally, women appear to be more susceptible to the …

Read More »